Particularly, the ability to induce mucus layer degradation [47] or modulate IL-10 by the B. fragilis polysaccharide A (PSA) [46] can be responsible for an immunosuppressed microenvironment that favours tumour progression. The gene discussed is IL10; the disease is neoplasm.